2m 2m 2m 2m 2m 2m 2m
- $105,916.00Market Cap
- -90.16%1-Year Change
- Packaged FoodsIndustry
BioAdaptives (BDPT)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 75
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
BioAdaptives' MyndMed™ nootropic supplement has been certified clean by TruShield™ Laboratory Services, meeting World Anti-Doping Agency (WADA) and UFC standards for athlete safety and supplement compliance.
08/20/2025, 11:54 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/03/2026
Company Profile
BioAdaptives, Inc. investigates, markets, and distributes natural plant, fungi, and algal-based products and medical devices for humans and animals. The company offers MyndMed for immediate cognitive enhancement, medium-term resilience and memory gains, and long-term neuroprotection and cognitive health; Zeranovia, a weight loss enhancer; Wynovia to help reduce the loss of lean muscle mass during dieting; and Xcellara, a regenerative wellness solution. It also provides canine products under the PawPa brand; dog chew products under the Regen brand; and Lung Flute, a medical device. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
Key Executives
- James Keener
Current Ownership Distribution
- Insiders30.3M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Other0 (0.00%)